These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30025705)

  • 1. New Onset Villous Atrophy in a Patient With Celiac Disease.
    Cartee AK; Reyes Genere JP; Oxentenko AS
    Gastroenterology; 2018 Oct; 155(4):988-989. PubMed ID: 30025705
    [No Abstract]   [Full Text] [Related]  

  • 2. Olmesartan-Induced Enteropathy.
    Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
    Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.
    Nielsen JA; Steephen A; Lewin M
    World J Gastroenterol; 2013 Oct; 19(40):6928-30. PubMed ID: 24187471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sprue-like enteropathy due to olmesartan: a case report].
    Agudo Fernández S
    Gastroenterol Hepatol; 2015 Feb; 38(2):108-9. PubMed ID: 24958550
    [No Abstract]   [Full Text] [Related]  

  • 5. Sprue-like enteropathy linked to olmesartan.
    Campos Ruiz A; Urtasun Arlegui L; Marra-López Valenciano C
    Rev Esp Enferm Dig; 2016 May; 108(5):292-3. PubMed ID: 26925975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan-associated sprue-like enteropathy.
    Stanich PP; Yearsley M; Meyer MM
    J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non celiac villous atrophy: more confusion or a new syndrome?].
    Téllez Villajos L; Crespo Pérez L; Cano Ruiz A
    Med Clin (Barc); 2015 Feb; 144(3):121-5. PubMed ID: 25015255
    [No Abstract]   [Full Text] [Related]  

  • 8. Olmesartan-induced enteropathy treated with budesonide.
    Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
    Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
    Kulai T; Arnason T; MacIntosh D; Igoe J
    Can J Gastroenterol Hepatol; 2016; 2016():6091571. PubMed ID: 27446852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enteropathy by olmesartan].
    Téllez Villajos L; Crespo Pérez L; Cano Ruiz A; Moreira Vicente V
    Med Clin (Barc); 2015 Feb; 144(3):140-1. PubMed ID: 25194976
    [No Abstract]   [Full Text] [Related]  

  • 11. Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue-A Case Report and Brief Literature Review.
    Desruisseaux C; Bensoussan M; Désilets E; Tran HK; Arcand R; Poirier G; Wisniewski A; Manière T
    Can J Gastroenterol Hepatol; 2016; 2016():4837270. PubMed ID: 27446843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In diarrhea of unknown origin also think of olmesartan!].
    Storr M
    MMW Fortschr Med; 2015 Mar; 157(4):34. PubMed ID: 25743974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enteropathy associated with chronic use of olmesartan].
    Téllez A; Pellicé M; Llobell A; Milisenda JC
    Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
    Ulla-Rocha JL; Lopez-Piñeiro S; Puga-Gimenez M
    Gastroenterol Hepatol; 2015 Oct; 38(8):514-5. PubMed ID: 25534549
    [No Abstract]   [Full Text] [Related]  

  • 15. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenous Enteritis is Unlikely a Form of Aggressive Celiac Disease Despite Sharing HLA-DQ2/DQ8 Genotypes.
    Kung VL; Liu TC; Ma C
    Am J Surg Pathol; 2018 Apr; 42(4):545-552. PubMed ID: 29324472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new spruelike disease as a cause of severe diarrhea].
    Halevy D; Teeuwen U; Kohlhof P
    Dtsch Med Wochenschr; 2014 Nov; 139(45):2290-3. PubMed ID: 25350242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe enteropathy with villous atrophy olmesartan medoxomil-associated].
    Nunge D; Eoche M; Fumery M; Nguyen-Khac E; Gras V; Andréjak M
    Therapie; 2013; 68(6):419-21. PubMed ID: 24246126
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical, laboratory, serological, and histological profile of sprue-like enteropathy associated with olmesartan use.
    Sáez González E; Díaz Jaime FC; Del Val Antoñana A
    Rev Esp Enferm Dig; 2016 Oct; 108(10):685-686. PubMed ID: 27109007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diarrhoea and malabsorption due to olmesartan use].
    van Beurden YH; Nijeboer P; Janssen J; Verbeek WH; Mulder CJ
    Ned Tijdschr Geneeskd; 2014; 158():A7370. PubMed ID: 24780574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.